These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 31154708)

  • 1. [Cervical cancer screning: from cytology to HPV testing].
    Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):289-292. PubMed ID: 31154708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical cancer screening today. The role of HPV DNA testing.
    Berman NR
    Adv Nurse Pract; 2006 Apr; 14(4):24-9; quiz 30. PubMed ID: 16972469
    [No Abstract]   [Full Text] [Related]  

  • 3. HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer.
    Ogilvie GS; Krajden M; van Niekerk D; Smith LW; Cook D; Ceballos K; Lee M; Gentile L; Gondara L; Elwood-Martin R; Peacock S; Stuart G; Franco EL; Coldman AJ
    Int J Cancer; 2017 Jan; 140(2):440-448. PubMed ID: 27685757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical cancer screening from Pap smear to human papillomavirus DNA testing.
    Jin XW; Xu H
    Compr Ther; 2001; 27(3):202-8. PubMed ID: 11569320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing for cervical cancer: new recommendations from the American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology.
    CA Cancer J Clin; 2012; 62(3):211-2. PubMed ID: 22418892
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing.
    van Rosmalen J; de Kok IM; van Ballegooijen M
    BJOG; 2012 May; 119(6):699-709. PubMed ID: 22251259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary human papillomavirus testing in organized cervical screening.
    Dillner J
    Curr Opin Obstet Gynecol; 2013 Feb; 25(1):11-6. PubMed ID: 23299089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can the test for human papillomavirus DNA be used as the stand-alone, first-line screening test for cervical cancer?
    Jin XW; McKenzie ML; Yen-Lieberman B
    Cleve Clin J Med; 2015 Apr; 82(4):213-5. PubMed ID: 25955454
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary HPV screening for cervical cancer.
    Bhatla N; Singhal S
    Best Pract Res Clin Obstet Gynaecol; 2020 May; 65():98-108. PubMed ID: 32291178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of self-collection devices for cytology and human papillomavirus DNA testing in cervical cancer screening.
    Bidus MA; Zahn CM; Maxwell GL; Rodriguez M; Elkas JC; Rose GS
    Clin Obstet Gynecol; 2005 Mar; 48(1):127-32. PubMed ID: 15725865
    [No Abstract]   [Full Text] [Related]  

  • 11. Urine-based HPV testing as a method to screen for cervical cancer.
    Fontenot HB
    Nurs Womens Health; 2015; 19(1):59-65. PubMed ID: 25690816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of HPV testing for cervical cancer screening in Israel.
    Levy T
    Isr Med Assoc J; 2017 Oct; 19(10):644-465. PubMed ID: 29103244
    [No Abstract]   [Full Text] [Related]  

  • 13. Rightsizing cervical cancer screening: comment on "Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone".
    Sawaya GF
    Arch Intern Med; 2010 Jun; 170(11):985-6. PubMed ID: 20548012
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlation between integration of high-risk HPV genome into human DNA detected by molecular combing and the severity of cervical lesions: first results of the EXPL-HPV-002 study.
    Bouchilloux S; Fer F; Lemée F; Barradeau S; Dvorak V; Kubickova S; Ventruba P; Tachezy R; Trnková M; Janda P; Abscheidt J; Annibal E; El Mhali D; Garcia F; Kech M; Pilger G; Bensimon A; Mahé F
    Ceska Gynekol; 2019; 84(2):84-92. PubMed ID: 31238677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of human papilloma virus testing in cervical cancer prevention.
    Fey MC; Beal MW
    J Midwifery Womens Health; 2004; 49(1):4-13. PubMed ID: 14710135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus testing for primary screening of cervical cancer precursors.
    Ratnam S; Franco EL; Ferenczy A
    Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):945-51. PubMed ID: 11008913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
    Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
    Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of HPV DNA testing in modern gynaecological practice.
    Ronco G; Giorgi Rossi P
    Best Pract Res Clin Obstet Gynaecol; 2018 Feb; 47():107-118. PubMed ID: 28918099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The difference in sensitivity between HPV testing and cytology for detecting current and future CIN2+ increases over time.
    Sasieni P
    Evid Based Med; 2014 Oct; 19(5):184. PubMed ID: 24785468
    [No Abstract]   [Full Text] [Related]  

  • 20. Patient safety and the next generation of HPV DNA tests.
    Simon K; Kondratovich MV; Hojvat S; Gutierrez A
    Am J Clin Pathol; 2011 May; 135(5):798-9; author reply 799-803. PubMed ID: 21502437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.